Latest / Stock Movers / Aegon Rises, WH Smith Plunges, Novonesis Falls
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look now at some stocks on the
- 0:18Speaker 3: move today in Europe. I'm Stephen Carroll and I'm joined
- 0:20Speaker 3: by Bloomberg's breaking news reporter Chloe Melee for more. Chloe,
- 0:23Speaker 3: good morning. Let's start with Agon then shares rising this morning.
- 0:27Speaker 3: What's going on?
- 0:28Speaker 4: Yeah, quite good day for Egg on the Dutch insurer today.
- 0:31Speaker 4: So it reported earnings that be expectations by quite a large.
- 0:35Speaker 1: Margin this morning.
- 0:36Speaker 4: And it also went from a net loss in last
- 0:39Speaker 4: year's first half to and their income for this first
- 0:42Speaker 4: half of six hundred million euros, so quite a reversal there.
- 0:46Speaker 4: And it also increased its Buyobeck program to four hundred
- 0:49Speaker 4: million euros. So kind of good news across the board
- 0:52Speaker 4: for Agon. Another piece of news that we've got today
- 0:54Speaker 4: from them is the intention to move its legal domicile
- 0:58Speaker 4: to the US, which was in the in the hope
- 1:00Speaker 4: to kind of better align with the geographic focus that
- 1:03Speaker 4: it has on the US.
- 1:04Speaker 1: At the moment.
- 1:06Speaker 4: Bloomberg Intelligence said that the move would facilitate comparisons with
- 1:10Speaker 4: a more appropriate peer group. But it said interestingly that
- 1:14Speaker 4: a potential challenge there could be that Dutch social values
- 1:18Speaker 4: are really deeply embedded in a gone in that company
- 1:20Speaker 4: and that might maybe chafe a little bit with the
- 1:23Speaker 4: US norms. Really, so we'll know more about this potential
- 1:26Speaker 4: pivot in December and the Capital markets day.
- 1:29Speaker 1: But in the meantime, the.
- 1:30Speaker 4: First half results really was really well received by the market.
- 1:34Speaker 3: Yeah, and d chair is currently up six and a
- 1:36Speaker 3: half percent in Amsterdam. However, what's gone on with w
- 1:39Speaker 3: H smith sales adown sales down, shared it down thirty
- 1:42Speaker 3: six percent?
- 1:43Speaker 1: Yeah, yeah, major and major drop this morning.
- 1:46Speaker 4: So yeah, the latest thirty six percent biggest drop on
- 1:48Speaker 4: record for wh Smith and that is because it lowered
- 1:52Speaker 4: its profit outlook for North America and that was due
- 1:54Speaker 4: to an accounting error. So it said that a financial
- 1:57Speaker 4: review found an overstatement of about thirty million pounds in
- 2:02Speaker 4: expected trading profit for the year that ended that will
- 2:05Speaker 4: end on August thirty first.
- 2:07Speaker 1: The revision then brings w H.
- 2:09Speaker 4: Smith's forecast down from fifty five million pounds to twenty
- 2:13Speaker 4: five million pounds in North America.
- 2:15Speaker 1: This is a major major drop.
- 2:17Speaker 4: This is particularly significant given that the company's strategy has
- 2:20Speaker 4: been focused on expanding in North American, especially in travel retail,
- 2:24Speaker 4: and so and Lissa are quite quite shocked by it,
- 2:27Speaker 4: and Lissa Goodbody said that the scale of that overstatement
- 2:30Speaker 4: was quite shocking and that seems to be kind of
- 2:32Speaker 4: the overall sentiment there. B I said that the part
- 2:37Speaker 4: of the revision is kind of unexplained as well, because
- 2:39Speaker 4: not all of it came from the understatement, this accounting understatement.
- 2:44Speaker 4: It also noted that there's risk from a consumer pullback
- 2:47Speaker 4: in travel retail as well, so it's not just the
- 2:50Speaker 4: accounting eraror but this accounting era was a massive one.
- 2:53Speaker 3: Okay, yeah, I mean a huge move in the share
- 2:55Speaker 3: price as a result as well. Let's go to Denmark next,
- 2:58Speaker 3: and novonicis what the needs from them.
- 3:00Speaker 4: So no vnicas it makes enzymes the for a bunch
- 3:04Speaker 4: of sectors of pharmaceutical sector, but also consumer and in
- 3:08Speaker 4: industrial end markets.
- 3:09Speaker 1: So enzymes that are used in.
- 3:11Speaker 4: Detergents, food, beer, whatever you name it, they make enzymes
- 3:15Speaker 4: for it. And the shares are down because they well,
- 3:19Speaker 4: they actually narrowed their guidance for the for the high
- 3:21Speaker 4: end of the ranger that should have been positive. But
- 3:24Speaker 4: what is driving the shares down is that there is
- 3:26Speaker 4: some weakness in the cells target for twenty thirty. So
- 3:29Speaker 4: it released both it's twenty thirty cells targets and its
- 3:33Speaker 4: results as well, and the City analyst said that the
- 3:35Speaker 4: new target's disappointed on margin especially, and it said that
- 3:39Speaker 4: evidence is kind of mounting that the pricing transformation will
- 3:44Speaker 4: not translate into the strong margin progress that many.
- 3:48Speaker 1: Had hoped for.
- 3:49Speaker 4: So there is some weakness then that is driving the
- 3:52Speaker 4: shares down this morning for that company.
- 3:55Speaker 2: The Stock Mover's report from Bloomberg Radio. Check back with
- 3:59Speaker 2: us throughout the for the latest roundup of companies making
- 4:02Speaker 2: news on Wall Street and for the latest market moving headlines.
- 4:06Speaker 2: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 4:10Speaker 2: dot com, and on Applecarplay and Android Auto with the
- 4:13Speaker 2: Bloomberg Business app.